Trial Profile
Phase 2, Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Six Oral Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2022
Price :
$35
*
At a glance
- Drugs Fexinidazole (Primary)
- Indications Chagas disease; Trypanosomiasis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 04 Aug 2022 Results published in the Clinical Infectious Diseases
- 22 Jan 2019 Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone-marrow toxicities from six trials published in the Antimicrobial Agents and Chemotherapy
- 17 Jul 2015 New trial record